During the past decade, Frisbie Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Frisbie Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 5 trials, followed by "National Cancer Institute (NCI)" with 4 trials sponsored, "ETOP IBCSG Partners Foundation" with 1 trials sponsored, "Eastern Cooperative Oncology Group" with 1 trials sponsored and "SWOG Cancer Research Network" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Frisbie Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Frisbie Hospital" are "Lymphoma" (3 trials), "Adult Acute Lymphoblastic Leukemia in Remission" (1 trials), "Clear Cell Renal Cell Carcinoma" (1 trials), "DS Stage I Plasma Cell Myeloma" (1 trials) and "DS Stage II Plasma Cell Myeloma" (1 trials). Many other conditions were trialed in "Frisbie Hospital" in a lesser frequency.

Most popular intervention types in "Frisbie Hospital" are "Drug" (8 trials), "Biological" (5 trials), "Other" (5 trials), "Radiation" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Quality-of-Life Assessment" (3 trials), "Placebo" (2 trials), "etoposide" (2 trials) and "rituximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Frisbie Hospital" are 9 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Frisbie Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Frisbie Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Frisbie Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".